ACVR2A & ACVR2B, Human (Bimagrumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-ACVR2A & ACVR2B, Human (Bimagrumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityACVR2A & ACVR2B, Human (Bimagrumab biosimilar)
CloneBimagrumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 lambda
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFCM, IP, ELISA, Neut, FuncS, IF, ICC, MRI
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human ACVR2A & ACVR2B Recombinant Antibody. Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013, it was announced that bimagrumab had received a breakthrough therapy designation for sporadic inclusion body myositis (sIBM) by the US Food and Drug Administration.
Immunogenn/a
Other NamesAnti-ACVR2A & ACVR2B Recombinant Antibody, Research Grade Bimagrumab, Anti-Human ACVR2A & ACVR2B Recombinant Antibody, BYM338, Antibody Drug Analogues, Monoclonal Antibody, YR1301, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1356922-05-8
Catalog #YR1301
Priceplease inquire
Order / More InfoACVR2A & ACVR2B, Human (Bimagrumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.